Table of Contents Table of Contents
Previous Page  600 / 916 Next Page
Information
Show Menu
Previous Page 600 / 916 Next Page
Page Background

S596

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S583–S644

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.918

EV0589

Genetic determinants of psychic

resilience after a diagnosis of cancer

M. Christensen

1 , A.

Drago

2 ,

1

Via University College, Via University College, Holstebro, Denmark

2

Psykiatrisk Forskningsenhed Vest, Department of Clinical Medicine,

Aarhus University, Herning, Denmark

Corresponding author.

Introduction

Co-morbidity between cancer and psychiatric dis-

orders including adjustment disorder, depressive disorders or angst

can seriously influence the prognosis and the quality of life of

patients.

Aim

The identification of the psychological and biological profile

of patients at risk for such co-morbidity is not yet available. Classical

candidate genes such as the BDNF, the 5-HTLPR and genes whose

products are involved in inflammatory events have received some

attention, but results are inconclusive.

Object and methods

In the present review the association

between cancer and psychiatric disorders is reviewed, a focus on

the investigation of the Gene X environment and the epigenetic

control over the activation of the HPA axis is proposed as a tool to

refine the definition of the biologic profile at risk for co-morbidity

between psychiatry and cancer.

Results and conclusion

Anumber of genes and socio-demographic

variables that may influence risk to suffer from a psychiatric dis-

order after a diagnosis of cancer is identified and discussed. The

identification of such biologic and socio-demographic profile is

instrumental in the identification of subjects at risk of a double

diagnosis, both somatic and psychiatric. An early identification of

such profile riskwould pave theway to the implementation of early

intervention strategies.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.919

EV0590

Is 22q11.2 deletion syndrome a

genetic subtype of schizophrenia?

R. Hernandez Anton

1 ,

, H. De La Red Gallego

1

, M. Gomez Garcia

1

,

A. Alonso Sanchez

1

, E. Mayor Toranzo

1

, J.A. Blanco Garrote

1

,

M. De Lorenzo Calzon

1

, M. Hernandez Garcia

1

, E. Dominguez

2

,

F. Uribe Ladron De Cegama

1

, V. Molina Rodriguez

1

1

Hospital Clinico Universitario Valladolid, Psiquiatria, Valladolid,

Spain

2

Hospital La Mancha Centro, Psiquiatria, Alcazar De San Juan, Spain

Corresponding author.

Introduction

22q11.2 deletion syndrome is a primary immuno-

deficiency due to micro-deletion on the large arm of chromosome

22. Patients suffer from several anomalies, including metal illness,

that such the case we present, mean a warning sign for further

study.

Methods

Twenty-one years-old male, with psychotic symptoms,

typical of schizophrenia, behavioral disorders and mental con-

fusion, plus epileptic episodes and psychomotor agitation. Two

previous incomes with the diagnosis of psychotic disorder not oth-

erwise specified. Treated with anti-psychotics at low doses with

inter-episode stability.

Background

Prematurity, low birth weight, neonatal asphyxia,

generalized seizures, otitis and recurrent urinary tract infections,

hypernasal voice, poor academic performance, difficulty relating.

Physical examination: hypernasal voice, furred tongue, dysmorphic

faces, scoliosis, hipotanía, stereotypes, delusions, auditory halluci-

nationsd negative symptoms.

Results

We considered the possibility of a neurodevelopmental

disorder, with a multidisciplinary approach, resulting in the diag-

nosis of paranoid schizophrenia and velocardiofacial syndrome,

which had gone unnoticed. Mean doses of clozapine, haloperidol

and topiramate were used. He accepted psychiatry and other spe-

cialties follow-up, since it requires a complex andmultidisciplinary

approach.

Conclusions

Definition of velocardiofacial Syndrome and lack of

consensus on terminology:

– syndrome 22q11.2 DS as genetic subtype of schizophrenia?

Opportunity to study the pathogenesis of schizophrenia;

– the importance of a comprehensive approach to early diagnosis,

clinical improvement and preventing complications.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.920

EV0591

The genetic study of computer game

addiction

D. Mavani

1 ,

, V. Soldatkin

2

, E. Mashkina

3

, A. Dyachenko

1

,

E. Karpova

1

, O. Bukhanovskaya

1

1

Scientific Center for Treatment and Rehabilitation “Phoenix”,

Psychiatry department, Rostov-on-Don, Russia

2

Rostov State Medical University, Psychiatry department,

Rostov-on-Don, Russia

3

South Federal University, Genetics department, Rostov-on-Don,

Russia

Corresponding author.

Introduction

Addiction to computer games (CA) is growing with

a lightning speed in whole world. Very few studies are focused in

the genetic basis of this disorder.

Objectives

To study the COMT and MAOA polymorphism in

addicts to computer games.

Methods

Totally 42 persons were included in this study, 22 of

them had CA and 20 were totally healthy. Out of 22 gamers, 10

persons had only CA. The rest of 12 patients suffered from another

psychiatric disorder besides of CA (Schizotypal disorder, depres-

sion, bipolar disorder). Their mean age was 16 years (15; 17) and

all of them were males.

Results

The total frequency of alleles 3R and 5R of MAOA gene

in patients with CA was 30.0%, which doesn’t have any statisti-

cal difference with the healthy persons. The genotype frequency

of Val158Met of COMT gene is high in CA rather than in healthy

persons (

2

= 6.85,

P

= 0.03). Also, the homozygotes Val are much

more in CA patients (59.1%) than in healthy persons (25%). On the

other hand, the Val/Met combination is lower in CA patients (18.2%)

than in healthy persons (55.0%).

Conclusion

The Val158Met polymorphism of gene COMT may

lead to CA formation.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.921

EV0592

Family-based association study

between the brain derived

neurotrophic factor (bdnf) gene and

the attention deficit hyperactivity

disorder in a Mexican population

J.P. Sánchez de la Cruz

1 ,

, A. López López

2

, C.A. Tovilla Zárate

1

,

R. Molina Sólis

2

, A. Valencia Hernández

2

, L. Gómez Valencia

2

,

M.M. Rivera Angles

2

, M.L. López Narváez

3

,

D.Y. Bermúdez Oca˜na

1